Follow-The-Filings

Security · featured owners

SOLV Solventum Corp.

Health Care COM SHS Equity as of 2026 Q2 among managers we track

  • 6 Owners
  • #249
  • Max 15.0%
  • Master 0.07%
  • $1.2B
  • 3 reduce

SOLV (Solventum Corp.) is held in 6 featured 13F books as of 2026 Q2. Nelson Peltz - Trian Fund Management is the largest tracked holder by portfolio weight (15.0%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 15.0% (Nelson Peltz - Trian Fund Management) · not free-float ownership

  1. Nelson Peltz 15.0%
  2. Christopher Davis reduce 2.1%
  3. Nehal Chopra 0.50%
  4. Richard Pzena reduce 0.09%
  5. Mairs & Power reduce 0.05%
  6. Kentucky Trust Co. 0.01%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Nelson Peltz - Trian Fund Management 2026 Q2 15.0% Hold 8,236,753 $635M history
Christopher Davis - Davis Selected Advisers 2026 Q2 2.1% Reduce −0.4% 6,307,729 $487M history
Richard Pzena - Pzena Investment Management 2026 Q2 0.09% Reduce −5.0% 417,770 $32M history
Mairs & Power 2026 Q2 0.05% Reduce −0.1% 72,441 $6M history
Nehal Chopra - Ratan Capital Management 2026 Q2 0.50% Hold 20,000 $2M history
Kentucky Trust Co. - Kentucky Trust 2026 Q2 0.01% Hold 156 $12K history

6 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 9 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 7.01,8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 5 rows shown

Filed Form Detail Links
4 Period Sep 1, 2026 Filing Doc
4 Period Aug 17, 2026 Filing Doc
4 Period May 15, 2026 · 11 forms Filing Doc
4 Period May 13, 2026 · 7 forms Filing Doc
4 Period Apr 30, 2026 · 5 forms Filing Doc

Updated 4 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2024 FY2025
Revenue $8.25B $8.32B
Gross profit $4.59B $4.45B
Gross margin * 55.6% 53.5%
Net income $0.479B $1.56B
Net margin * 5.8% 18.7%

Balance sheet

Metric FY2024 FY2025
Total current assets $3.25B $3.86B
Total non-current assets * $11.21B $10.44B
Total assets $14.46B $14.29B
Total current liabilities $2.7B $3.14B
Total non-current liabilities * $8.8B $6.11B
Total equity $2.96B $5.05B

Cash flow

Metric FY2024 FY2025
Cash from operations $1.18B $0.369B
Cash from investing -$0.38B $2.8B
Cash from financing -$0.24B -$3.06B
Net change in cash $568M $116M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders